论文部分内容阅读
利达克公司的ｎ－ｄｏｃｏｓａｎｏｌ开始Ⅱ期临床利达克制药公司（Ｌｉｄａｋ）宣布，它已开始进行对ＡＩＤＳ病人局部使用１０％ｎ－ｄｏ－ｃｏｓａｎｏｌ霜分别治疗卡波济肉瘤皮损（ＫＳ）和传染性软疣（ＭＣ）的Ⅱ期临床试验。临床前研究表明该药具有细胞生长抑制性质...
Lidak’s n-docosanol Starts Phase II Clinical Lidak Corporation announced that it has started treatment of Kaposi’s sarcoma lesions (KS) with topical 10% n-do-cosanol cream for AIDS patients, And molluscum contagiosum (MC) phase Ⅱ clinical trials. Preclinical studies show that the drug has cytostatic properties ...